Seagen
SGEN
#563
Rank
S$54.89 B
Marketcap
S$290.98
Share price
-0.07%
Change (1 day)
57.05%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -S$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are S$2.30 Billion. In 2022 the company made an earning of -S$0.78 Billion, an increase over its 2021 earnings that were of -S$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$1.07 Billion36.75%
2022 -S$0.78 Billion-10.13%
2021 -S$0.87 Billion-214.28%
2020 S$0.75 B-370.63%
2019 -S$0.29 Billion-15.17%
2018 -S$0.34 Billion32.79%
2017 -S$0.25 Billion37.19%
2016 -S$0.19 Billion18%
2015 -S$0.16 Billion56.34%
2014 -S$98.42 Million23.07%
2013 -S$79.97 Million
2011 -S$0.19 Billion111.72%
2010 -S$86.76 Million-19.63%
2009 -S$0.11 Billion-7.55%
2008 -S$0.12 Billion64.95%
2007 -S$70.79 Million38.4%
2006 -S$51.15 Million25.36%
2005 -S$40.8 Million-14.86%
2004 -S$47.92 Million61.92%
2003 -S$29.6 Million-7.67%
2002 -S$32.06 Million6.76%
2001 -S$30.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.07 B-1,599.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.11 B-309.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.42 B-340.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.21 B-1,116.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.85 B-1,279.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$78.72 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-S$79.87 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion-67.59%๐Ÿ‡บ๐Ÿ‡ธ USA